154 related articles for article (PubMed ID: 25340645)
1. Surrogate receptivity to participation in critical illness genetic research: aligning research oversight and stakeholder concerns.
Freeman BD; Butler K; Bolcic-Jankovic D; Clarridge BR; Kennedy CR; LeBlanc J; Chandros Hull S
Chest; 2015 Apr; 147(4):979-988. PubMed ID: 25340645
[TBL] [Abstract][Full Text] [Related]
2. Perspectives of Decisional Surrogates and Patients Regarding Critical Illness Genetic Research.
Freeman BD; Bolcic-Jankovic D; Kennedy CR; LeBlanc J; Eastman A; Barillas J; Wittgen CM; Indsey K; Mahmood RS; Clarridge BR
AJOB Empir Bioeth; 2016 Jan; 7(1):39-47. PubMed ID: 26752784
[TBL] [Abstract][Full Text] [Related]
3. Genetic research and testing in critical care: surrogates' perspective.
Freeman BD; Kennedy CR; Coopersmith CM; Zehnbauer BA; Buchman TG
Crit Care Med; 2006 Apr; 34(4):986-94. PubMed ID: 16484903
[TBL] [Abstract][Full Text] [Related]
4. Perspectives of surrogate decision makers for critically ill patients regarding gene variation research.
Iverson E; Celious A; Kennedy CR; Shehane E; Eastman A; Warren V; Freeman BD
Genet Med; 2013 May; 15(5):368-73. PubMed ID: 23154525
[TBL] [Abstract][Full Text] [Related]
5. Surrogate and patient discrepancy regarding consent for critical care research.
Newman JT; Smart A; Reese TR; Williams A; Moss M
Crit Care Med; 2012 Sep; 40(9):2590-4. PubMed ID: 22732283
[TBL] [Abstract][Full Text] [Related]
6. Surrogate consent for genomics research in intensive care.
Shelton AK; Fish AF; Cobb JP; Bachman JA; Jenkins RL; Battistich V; Freeman BD
Am J Crit Care; 2009 Sep; 18(5):418-26; quiz 427. PubMed ID: 19723862
[TBL] [Abstract][Full Text] [Related]
7. Voluntary participation and comprehension of informed consent in a genetic epidemiological study of breast cancer in Nigeria.
Marshall PA; Adebamowo CA; Adeyemo AA; Ogundiran TO; Strenski T; Zhou J; Rotimi CN
BMC Med Ethics; 2014 May; 15():38. PubMed ID: 24885380
[TBL] [Abstract][Full Text] [Related]
8. Does difficulty functioning in the surrogate role equate to vulnerability in critical illness research? Use of path analysis to examine the relationship between difficulty providing substituted judgment and receptivity to critical illness research participation.
Clarridge BR; Bolcic-Jankovic D; LeBlanc J; Mahmood RS; Kennedy CR; Freeman BD
J Crit Care; 2015 Dec; 30(6):1310-6. PubMed ID: 26304514
[TBL] [Abstract][Full Text] [Related]
9. Patients' and surrogates' perspective on research and testing in critical care.
Rubulotta F
Crit Care Med; 2007 Jan; 35(1):328; author reply 328-9. PubMed ID: 17197795
[No Abstract] [Full Text] [Related]
10. Return of Research-Related Genetic Test Results and Genetic Discrimination Concerns: Facilitators and Barriers of Genetic Research Participation in Diverse Groups.
Burnett-Hartman AN; Blum-Barnett E; Carroll NM; Madrid SD; Jonas C; Janes K; Alvarado M; Bedoy R; Paolino V; Aziz N; McGlynn EA
Public Health Genomics; 2020; 23(1-2):59-68. PubMed ID: 32289795
[TBL] [Abstract][Full Text] [Related]
11. Attitudes of relatives of patients in intensive care and emergency departments to surrogate consent to research on incapacitated participants.
Stephenson AC; Baker S; Zeps N
Crit Care Resusc; 2007 Mar; 9(1):40-50. PubMed ID: 17352666
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluating ethical concerns in planned emergency research involving critically ill patients: an interpretation of the guidance document from the United States Food and Drug Administration.
Smischney NJ; Onigkeit JA; Hinds RF; Nicholson WT
J Clin Ethics; 2015; 26(1):61-7. PubMed ID: 25794295
[TBL] [Abstract][Full Text] [Related]
13. Considerations in the construction of an instrument to assess attitudes regarding critical illness gene variation research.
Freeman BD; Kennedy CR; Bolcic-Jankovic D; Eastman A; Iverson E; Shehane E; Celious A; Barillas J; Clarridge B
J Empir Res Hum Res Ethics; 2012 Feb; 7(1):58-70. PubMed ID: 22378135
[TBL] [Abstract][Full Text] [Related]
14. Exploring determinants of surrogate decision-maker confidence: an example from the ICU.
Bolcic-Jankovic D; Clarridge BR; LeBlanc JL; Mahmood RS; Roman AM; Freeman BD
J Empir Res Hum Res Ethics; 2014 Oct; 9(4):76-85. PubMed ID: 25747298
[TBL] [Abstract][Full Text] [Related]
15. Critical illness research involving collection of genomic data: the conundrum posed by low levels of genomic literacy among surrogate decision makers for critically ill patients.
Iverson E; Celious A; Shehane E; Oerke M; Warren V; Eastman A; Kennedy CR; Freeman BD
J Empir Res Hum Res Ethics; 2013 Jul; 8(3):53-7. PubMed ID: 23933776
[TBL] [Abstract][Full Text] [Related]
16. Ethical considerations in consenting critically ill patients for bedside clinical care and research.
Rincon F; Lee K
J Intensive Care Med; 2015 Mar; 30(3):141-50. PubMed ID: 24019298
[TBL] [Abstract][Full Text] [Related]
17. Substitute decisions about genetic testing in critical care research: a glimpse behind the curtain.
Lavery JV; Slutsky AS
Crit Care Med; 2006 Apr; 34(4):1257-9. PubMed ID: 16550080
[No Abstract] [Full Text] [Related]
18. Surrogate consent for genetic testing, the reconsent process, and consent for long-term outcomes in acute respiratory distress syndrome trials.
Smart A; Thompson BT; Needham DM; Hopkins RO; Williams A; Burnham EL; Moss M;
Am J Respir Crit Care Med; 2013 Dec; 188(11):1370-3. PubMed ID: 24289781
[No Abstract] [Full Text] [Related]
19. Informed consent, participation in, and withdrawal from a population based cohort study involving genetic analysis.
Matsui K; Kita Y; Ueshima H
J Med Ethics; 2005 Jul; 31(7):385-92. PubMed ID: 15994356
[TBL] [Abstract][Full Text] [Related]
20. Re-examining ethical obligations in the intensive care unit: HIV disclosure to surrogates.
Vernillo AT; Wolpe PR; Halpern SD
Crit Care; 2007; 11(2):125. PubMed ID: 17466079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
